GENE ONLINE|News &
Opinion
Blog

2025-11-30|

Lactylation Identified as Key Link Between Immune Metabolism and Epigenetic Regulation

by GOAI
Share To

Researchers have identified lactylation, a post-translational modification involving the addition of lactate molecules to lysine residues on proteins, as a key link between immune metabolism and epigenetic regulation. This discovery has drawn significant attention in the fields of immunology and epigenetics due to its potential implications for understanding immune system function and its role in diseases such as rheumatic immune disorders.

Lactylation represents a novel mechanism by which cellular metabolism interacts with gene expression. By modifying proteins through the attachment of lactate moieties, this process appears to influence both metabolic pathways and epigenetic markers that regulate gene activity. The findings suggest that lactylation may play an important role in modulating immune responses, particularly in conditions where metabolic changes are prominent. Researchers continue to investigate how this modification impacts broader biological processes and its potential applications in medical science.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 30, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top